SCHEMBL10567778

SCHEMBL10567778

CC(=O)N(c1ccncc1)c1ccc(C)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC7 O00311 1/20 0.43
PLK4 O00444 1/20 0.43
DAPK3 O43293 1/20 0.43
ROCK2 O75116 1/20 0.43
CHEK2 O96017 1/20 0.43
PIM1 P11309 1/20 0.43
FLT4 P35916 1/20 0.43
KDR P35968 1/20 0.43
GSK3A P49840 1/20 0.43
GSK3B P49841 1/20 0.43
RPS6KA3 P51812 1/20 0.43
PRKX P51817 1/20 0.43
PLK1 P53350 1/20 0.43
CSNK1G2 P78368 1/20 0.43
PRKCZ Q05513 1/20 0.43
ROCK1 Q13464 1/20 0.43
PRKG1 Q13976 1/20 0.43
CDC42BPA Q5VT25 1/20 0.43
AURKB Q96GD4 1/20 0.43
PLK3 Q9H4B4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10566831 0.85 GAA (0.41) RAB9ASMN1; SMN2ALDH1A1GAACHRM5
SCHEMBL10670734 0.81 CHRM5 (0.42) RAB9ASMN1; SMN2ALDH1A1GAACHRM5
SCHEMBL14817119 0.81 RAB9A (0.45) RAB9AGAAPTGS2NPC1LMNA
SCHEMBL10669577 0.80 NPSR1 (0.59) RAB9AALDH1A1GAAKDM4ENPC1
SCHEMBL6341114 0.79 CSNK1G1 (0.43) CDC7PLK4DAPK3ROCK2CHEK2
SCHEMBL10572176 0.78 ALDH1A1 (0.44) CDC7PLK4DAPK3ROCK2CHEK2
SCHEMBL9239773 0.77 MEN1 (0.46) RAB9ASMN1; SMN2ALDH1A1KDM4ENPC1
SCHEMBL20628911 0.75 CHRM5 (0.46) RAB9ASMN1; SMN2ALDH1A1CHRM5CHKA
SCHEMBL7742836 0.75 HCAR2 (0.46) RAB9ASMN1; SMN2KDM4ENPC1LMNA
SCHEMBL12593354 0.74 CHRM5 (0.50) RAB9ASMN1; SMN2ALDH1A1GAACHRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4855308-A Method of treating senile cognitive decline with N'-substituted aminopyridine adrenergic agents WARNER-LAMBERT COMPANY (US) 1989-08-08 US claimed
US-4855308-A Method of treating senile cognitive decline with N'-substituted aminopyridine adrenergic agents WARNER-LAMBERT COMPANY (US) 1989-08-08 US disclosed